KUMJ | VOL. 22 | NO. 4 | ISSUE 88 | OCTOBER. - DECEMBER. 2024
Outcome of Transurethral Vaporisation of Prostate in Small Volume Prostate: A prospective observational study
Dahal R, Adhikari B, Mishra U, Shah AK, Basnet RB, Shrestha A, Shrestha PM
Abstract: Background
Benign Enlargement of Prostate is common in aging men. Transurethral vaporisation
of prostate is one modality of minimal invasive management of benign enlargement
of prostate. This study assesses the efficacy and safety of transurethral vaporisation
of prostate in small volume prostate.
Objective
To assess the efficacy and safety of bipolar plasma vaporisation of small volume
prostate (Prostate Volume less than 40 grams).
Method
A total of 40 patients with prostate volume less than 40 grams and indications for
operative management of benign enlargement of prostate were included. Patients
with prior prostate surgery, urethral stricture surgery, presence of vesical calculus,
urethral stricture and neurogenic bladder were excluded. Preoperative prostate
size was assessed by transrectal ultrasonography. Comparison of preoperative and
postoperative hemoglobin, sodium, international prostate symptom score and
maximum flow rate was done. Perioperative complications were documented.
Result
The mean age of patients was 66.88 ± 9.09 years and the mean size of prostate was
32.52 ± 4.66 grams. Significant improvement in IPSS (preoperative 22, postoperative
9) and Qmax (preoperative 8.4 ml/min, postoperative 18.5 ml/min) was noted.
There was significant drop in hemoglobin (p < 0.001) but no patients required
blood transfusion. There was significant drop in sodium (p < 0.001) but no patients
developed transurethral resection syndrome. Most complications were Clavien
grade I. Two patients required recatheterization and all were catheter free on follow
up. Two patients developed urethral stricture.
Conclusion
Bipolar transurethral vaporisation of Prostate is effective and safe treatment option
for prostate volume less than 40 grams.
Keyword : Bipolar plasma vaporisation, Lower urinary tract symptoms, Prostate symptoms
